CIK: 0001631134 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $1,317,585 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics, Inc. | 1,953,077 | $247,631 | 18.8% | $26.41 | — | COMM | 48576A100 |
| NTRA | Natera Inc | 3,102,960 | $126,229 | 9.6% | $9.81 | +512.6% | COMM | 632307104 |
| — | Cincor Pharma, Inc. | 5,573,949 | $97,767 | 7.4% | $17.54 | — | COMM | 17240Y109 |
| VERA | Vera Therapeutics, Inc. | 3,181,442 | $74,732 | 5.7% | $16.04 | +34.1% | CL A | 92337R101 |
| — | Aerovate Therapeutics, Inc. | 3,758,686 | $68,897 | 5.2% | $22.83 | — | COMM | 008064107 |
| QQQ | Invesco QQQ Trust Series 1 | 175,000 | $63,445 | 4.8% | — | — | Put | 46090E103 |
| ASND | Ascendis Pharma A/S | 499,824 | $58,659 | 4.5% | $69.98 | — | ADR | 04351P101 |
| AZN | AstraZeneca PLC | 553,903 | $36,746 | 2.8% | $66.34 | — | ADR | 046353108 |
| UTHR | United Therapeutics Corp | 199,183 | $35,735 | 2.7% | $129.60 | +47.0% | COMM | 91307C102 |
| IWM | iShares Russell 2000 ETF | 150,000 | $30,791 | 2.3% | — | — | Put | 464287655 |
| — | Y-mAbs Therapeutics, Inc | 2,194,278 | $26,068 | 2.0% | $26.75 | — | COMM | 984241109 |
| VRTX | Vertex Pharmaceuticals Inc | 95,003 | $24,793 | 1.9% | $237.33 | 0.0% | COMM | 92532F100 |
| — | Horizon Therapeutics PLC | 232,894 | $24,503 | 1.9% | $108.84 | — | COMM | G46188101 |
| DXCM | Dexcom Inc | 40,265 | $20,600 | 1.6% | $99.68 | +9.7% | COMM | 252131107 |
| RGNX | Regenxbio Inc | 614,085 | $20,381 | 1.5% | $34.35 | -19.1% | COMM | 75901B107 |
| ZTS | Zoetis Inc | 106,574 | $20,099 | 1.5% | $190.28 | 0.0% | COMM | 98978V103 |
| — | Reata Pharmaceuticals Inc | 602,545 | $19,739 | 1.5% | $32.76 | — | COMM | 75615P103 |
| — | Sierra Oncology Inc | 572,297 | $18,342 | 1.4% | $28.28 | — | COMM | 82640U404 |
| XBI | Spdr S&P Biotech Etf | 200,000 | $17,976 | 1.4% | — | — | Put | 78464A870 |
| — | Iveric Bio Inc | 1,021,211 | $17,187 | 1.3% | $16.58 | — | COMM | 46583P102 |
| TVTX | Travere Therapeutics Inc | 658,249 | $16,963 | 1.3% | $24.05 | +10.4% | COMM | 89422G107 |
| GH | Guardant Health Inc | 239,995 | $15,897 | 1.2% | $104.91 | -34.8% | COMM | 40131M109 |
| — | ChemoCentryx Inc | 573,684 | $14,382 | 1.1% | $29.48 | — | COMM | 16383L106 |
| BMRN | Biomarin Pharmaceutical Inc | 176,533 | $13,611 | 1.0% | $83.10 | +0.7% | COMM | 09061G101 |
| — | Nextcure, Inc | 2,671,856 | $12,985 | 1.0% | $10.01 | — | COMM | 65343E108 |
| PTGX | Protagonist Therapeutics Inc | 547,441 | $12,963 | 1.0% | $27.77 | +1.4% | COMM | 74366E102 |
| SNDX | Syndax Pharmaceuticals Inc | 717,064 | $12,463 | 0.9% | $17.69 | -4.8% | COMM | 87164F105 |
| — | Checkmate Pharmaceuticals Inc | 3,606,707 | $11,505 | 0.9% | $11.51 | — | COMM | 162818108 |
| — | Inhibrx Inc | 514,640 | $11,466 | 0.9% | $37.60 | — | COMM | 45720L107 |
| IMTX | Immatics NV | 1,268,063 | $10,132 | 0.8% | $11.29 | -19.3% | COMM | N44445109 |
| — | Jounce Therapeutics Inc | 1,481,219 | $10,057 | 0.8% | $7.80 | — | COMM | 481116101 |
| — | CTI Biopharma Corp | 1,952,691 | $9,119 | 0.7% | $4.67 | — | COMM | 12648L601 |
| — | Adicet Bio Inc | 416,289 | $8,313 | 0.6% | $18.12 | — | COMM | 007002108 |
| — | Inozyme Pharma, Inc. | 2,028,308 | $8,296 | 0.6% | $26.29 | — | COMM | 45790W108 |
| — | Bolt Biotherapeutics, Inc. | 2,754,437 | $7,547 | 0.6% | $32.91 | — | COMM | 097702104 |
| — | ChemoCentryx Inc | 300,000 | $7,521 | 0.6% | — | — | Call | 16383L906 |
| GRTX | Galera Therapeutics, Inc | 3,083,712 | $7,339 | 0.6% | $12.19 | -78.6% | COMM | 36338D108 |
| XNCR | Xencor Inc | 273,992 | $7,310 | 0.6% | $37.91 | -14.9% | COMM | 98401F105 |
| — | Akouos, Inc. | 1,515,074 | $7,197 | 0.5% | $22.50 | — | COMM | 00973J101 |
| BCYC | Bicycle Therapeutics PLC | 163,559 | $7,177 | 0.5% | $43.88 | — | ADR | 088786108 |
| — | ObsEva SA | 4,749,623 | $7,172 | 0.5% | $13.49 | — | COMM | H5861P103 |
| SRPT | Sarepta Therapeutics Inc | 88,880 | $6,943 | 0.5% | $75.81 | +1.0% | COMM | 803607100 |
| — | ImmunoGen Inc | 1,428,169 | $6,798 | 0.5% | $7.42 | — | COMM | 45253H101 |
| — | Nucana Plc | 5,599,999 | $5,594 | 0.4% | $9.47 | — | ADR | 67022C106 |
| FULC | Fulcrum Therapeutics Inc | 229,509 | $5,428 | 0.4% | $19.74 | -28.3% | COMM | 359616109 |
| PTGX | Protagonist Therapeutics Inc | 200,000 | $4,736 | 0.4% | $27.77 | +1.4% | Call | 74366E102 |
| GERN | Geron Corp | 1,904,762 | $2,590 | 0.2% | $1.11 | 0.0% | COMM | 374163103 |
| PFE | Pfizer Inc | 49,378 | $2,556 | 0.2% | $42.47 | 0.0% | COMM | 717081103 |
| — | Nucana Plc | 2,400,000 | $2,398 | 0.2% | $4.99 | — | Ordinary Shares | GB00BYWYV |
| CYTK | Cytokinetics Inc | 62,944 | $2,317 | 0.2% | $22.36 | +58.9% | COMM | 23282W605 |
| — | Intercept Pharmaceuticals Inc | 100,000 | $1,627 | 0.1% | — | — | Call | 45845P108 |
| — | Synlogic Inc. | 574,972 | $1,380 | 0.1% | $9.38 | — | COMM | 87166L100 |
| GERN | Geron Corp | 1,000,000 | $1,360 | 0.1% | $1.11 | 0.0% | Call | 374163103 |
| AMLX | Amylyx Pharmaceuticals Inc | 100,000 | $1,285 | 0.1% | $22.45 | 0.0% | COMM | 03237H101 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $883 | 0.1% | $8.36 | -25.7% | COMM | 70465T107 |
| — | Mink Therapeutics Inc | 331,002 | $745 | 0.1% | $4.46 | — | COMM | 603693102 |
| — | Fusion Pharmaceuticals Inc | 78,066 | $607 | 0.0% | $7.92 | — | COMM | 36118A100 |
| PODD | Insulet Corp | 1,066 | $284 | 0.0% | $270.80 | -9.4% | COMM | 45784P101 |
| PTCT | PTC Therapeutics Inc | 3,480 | $130 | 0.0% | $47.53 | -18.9% | COMM | 69366J200 |
| INSM | Insmed Inc | 5,368 | $126 | 0.0% | $31.01 | -25.1% | COMM | 457669307 |
| HRTX | Heron Therapeutics Inc | 11,060 | $63 | 0.0% | $13.62 | -46.3% | COMM | 427746102 |